Genetic polymorphisms of MMP1, MMP3 and MMP7gene promoter and risk of colorectal adenoma
Authors:
- Astrid LièvreALAstrid Lièvre
- Jacqueline MiletJMJacqueline Milet
- Jérôme CarayolJCJérôme Carayol
- Delphine Le CorreDCDelphine Le Corre
- Chantal MilanCMChantal Milan
- Alexandre ParienteAPAlexandre Pariente
- Bernard NaletBNBernard Nalet
- Jacques LafonJLJacques Lafon
- Jean FaivreJFJean Faivre
- Claire Bonithon-KoppCBClaire Bonithon-Kopp
- Sylviane OlschwangSOSylviane Olschwang
- Catherine Bonaiti-PelliéCBCatherine Bonaiti-Pellié
Open Access
- 24 November 2006
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 6 (1) , 270
Abstract
Background: Matrix metalloproteinases (MMP) have been shown to play a role in colorectal cancer (CRC). More recently, MMP1, MMP3 and MMP7 functional gene promoter polymorphisms have been found to be associated with CRC occurrence and prognosis. To document the role of MMP polymorphisms in the early step of colorectal carcinogenesis, we investigated their association with colorectal adenoma risk in a case-control study comprising 295 patients with large adenomas (LA), 302 patients with small adenomas (SA) and 568 polyp-free (PF) controls. Methods: Patients were genotyped using automated fragment analysis for MMP1 -1607 ins/del G and MMP3 -1612 ins/delA (MMP3.1) polymorphisms and allelic discrimination assay for MMP3 -709 A/G (MMP3.2) and MMP7 -181 A/G polymorphisms. Association between MMP genotypes and colorectal adenomas was first tested for each polymorphism separately and then for combined genotypes using the combination test. Adjustment on relevant variables and estimation of odds ratios were performed using unconditional logistic regression. Results: No association was observed between the polymorphisms and LA when compared to PF or SA. When comparing SA to PF controls, analysis revealed a significant association between MMP3 -1612 ins/delA polymorphism and SA with an increased risk associated with the 6A/6A genotype (OR = 1.67, 95%CI: 1.20–2.34). Using the combination test, the best association was found for MMP3.1-MMP1 (p = 0.001) with an OR of 1.88 (95%CI: 1.08–3.28) for the combined genotype 2G/2G-6A/6A estimated by logistic regression. Conclusion: These data show a relation between MMP1 -1607 ins/del G and MMP3 -1612 ins/delA combined polymorphisms and risk of SA, suggesting their potential role in the early steps of colorectal carcinogenesis.Keywords
This publication has 49 references indexed in Scilit:
- Low compliance with colonoscopic screening in first‐degree relatives of patients with large adenomasAlimentary Pharmacology & Therapeutics, 2006
- Association of Ets-related transcriptional factor E1AF expression with overexpression of matrix metalloproteinases, COX-2 and iNOS in the early stage of colorectal carcinogenesisCarcinogenesis, 2005
- Colorectal Carcinoma Susceptibility and Metastases Are Associated with Matrix Metalloproteinase-7 Promoter PolymorphismsClinical Chemistry, 2003
- New functions for the matrix metalloproteinases in cancer progressionNature Reviews Cancer, 2002
- Allele-Specific Regulation of Matrix Metalloproteinase-7 Promoter Activity Is Associated With Coronary Artery Luminal Dimensions Among Hypercholesterolemic PatientsArteriosclerosis, Thrombosis, and Vascular Biology, 2001
- The 5A/6A polymorphism in the promoter of the stromelysin-1 (MMP-3) gene predicts progression of angiographically determined coronary artery disease in men in the LOCAT gemfibrozil studyAtherosclerosis, 1998
- Preliminary report: genetic variation in the human stromelysin promoter is associated with progression of coronary atherosclerosis.Heart, 1995
- Expression of Matrilysin mRNA in Colorectal Adenomas and Its Induction by Truncated FibronectinBiochemical and Biophysical Research Communications, 1994
- Adenomatous polyps and atherosclerosis: An autopsy study of Japanese men in HawaiiInternational Journal of Cancer, 1986
- Atherosclerosis and polyps of the colon. Quantification of precursors of coronary heart disease and colon cancerJournal of Chronic Diseases, 1982